Evaluating the Compatibility of New Recombinant Protein Antigens (Trivalent NRRV) with a Mock Pentavalent Combination Vaccine Containing Whole-Cell Pertussis: Analytical and Formulation Challenges (Dataset)
Kumar, Prashant Holland, David A. Secrist, Kathryn Taskar, Poorva Dotson, Brandy Saleh-Birdjandi, Soraia Adewunmi, Yetunde Doering, Jennifer Mantis, Nicholas J. Volkin, David B.
Kumar, Prashant
Holland, David A.
Secrist, Kathryn
Taskar, Poorva
Dotson, Brandy
Saleh-Birdjandi, Soraia
Adewunmi, Yetunde
Doering, Jennifer
Mantis, Nicholas J.
Volkin, David B.
Citations
Altmetric:
Abstract
Introducing new recombinant protein antigens to existing pediatric combination vaccines is important in improving coverage and affordability, especially in low- and middle-income countries (LMICs). This case-study highlights the analytical and formulation challenges encountered with three recombinant non-replicating rotavirus vaccine (NRRV) antigens (t-NRRV formulated with Alhydrogel® adjuvant, AH) combined with a mock multidose formulation of a pediatric pentavalent vaccine used in LMICs. This complex formulation contained (1) vaccine antigens (i.e., whole-cell pertussis (wP), diphtheria (D), tetanus (T), Haemophilus influenza (Hib), and hepatitis B (HepB), (2) a mixture of aluminum-salt adjuvants (AH and Adju-Phos®, AP), and (3) a preservative (thimerosal, TH). Selective, stability-indicating competitive immunoassays were developed to monitor binding of specific mAbs to each antigen, except wP which required the setup of a mouse immunogenicity assay. Simple mixing led to the desorption of t-NRRV antigens from AH and increased degradation during storage. These deleterious effects were caused by specific antigens, AP, and TH. An AH-only pentavalent formulation mitigated t-NRRV antigen desorption; however, the Hib antigen displayed previously reported AH-induced instability. The same rank-ordering of t-NRRV antigen stability (P[8] > P[4] > P[6]) was observed in mock pentavalent formulations and with various preservatives. The lessons learned are discussed to enable future multidose, combination vaccine formulation development with new vaccine candidates.
Description
Date
2024
Journal Title
Journal ISSN
Volume Title
Publisher
MDPI
Collections
Research Projects
Organizational Units
Journal Issue
Keywords
Pediatric combination vaccine, Non-replicating rotavirus vaccine, Diphtheria, Tetanus, Whole-cell pertussis, Hepatitis B, Haemophilus influenzae, Formulation, Compatibility, Stability, Preservatives